Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Biotech

Beam’s sickle cell results signal Casgevy, Lyfgenia showdown

The base-edited cell therapy kept patients from experiencing the most severe effects of the disease and prevented hospitalization for a year.

Michael Gibney Nov 10, 2026 3:19pm

In Laboratory Over the Shoulder View of Scientist in Protective Clothes Doing Research on a Personal Computer

PepGen’s stock doubles as midphase DM1 data wow analysts

Nov 10, 2026 10:21am

Use Kidney Genetics to Strengthen Clinical Trial Design

Brought to you by Natera

AstraZeneca buys partner Omniose for bacterial vaccine tech

Nov 10, 2026 10:16am

Advanced Analytics Help Reduce Control Animal Use While Preserving Scientific Rigor

How Virtual Control Groups Are Shaping Safety Studies

Brought to you by Charles River Laboratories

Fierce Biotech Fundraising Tracker '26: Oyster, Delix & more

Nov 10, 2026 10:00am